119 HR 5160
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Latest Action
Referred to the House Committee on Energy and Commerce.
2025-09-04
Read the Bill
Primary sources on Congress.gov:
Cosponsors (showing 10 of 17)
D · Matsui, Doris O. (California)R · Bilirakis, Gus M. (Florida)D · Pingree, Chellie (Maine)R · Tenney, Claudia (New York)D · Mfume, Kweisi (Maryland)R · Fischbach, Michelle (Minnesota)D · Dingell, Debbie (Michigan)D · Gottheimer, Josh (New Jersey)R · Aderholt, Robert B. (Alabama)R · Malliotakis, Nicole (New York)Markets vs Bill
No directly-mapped prediction markets indexed yet for this bill's policy domain.
Cite this page
APA
Apprised.news. (n.d.). 119 HR 5160: Stem Cell Therapeutic and Research Reauthorization Act of 2025. Retrieved 2026-05-13, from https://apprised.news/bill/119hr5160
MLA
"119 HR 5160: Stem Cell Therapeutic and Research Reauthorization Act of 2025." Apprised.news. Web. 2026-05-13. <https://apprised.news/bill/119hr5160>.
Chicago
"119 HR 5160: Stem Cell Therapeutic and Research Reauthorization Act of 2025." Apprised.news. Accessed 2026-05-13. https://apprised.news/bill/119hr5160.
BibTeX
@misc{apprised_119_hr_5160_stem_cell_therapeutic_and_re,
title = {119 HR 5160: Stem Cell Therapeutic and Research Reauthorization Act of 2025},
publisher = {Apprised.news},
url = {https://apprised.news/bill/119hr5160},
note = {Accessed 2026-05-13}
}